Pilot Study of Autologous Anti-CD22 Chimeric Antigen Receptor Redirected T Cells In Patients With Chemotherapy Resistant Or Refractory Acute Lymphoblastic Leukemia

Clinical trial NCT02588456 · TERMINATED

Trial details

NCT number

NCT02588456

Sponsor

University of Pennsylvania

Status

TERMINATED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2015-10-01

Primary completion

2017-09-01

Enrollment

5

View on ClinicalTrials.gov